Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany) and Kaneka Corporation (Japan) are Leading Players in the Peptide Synthesis Market
The global peptide synthesis market size is projected to reach USD 859 million by 2028 from 601 million in 2023, at a CAGR of 7.4% during the forecast period. The growth of this market is mainly driven by a notable surge in research endeavors and substantial investments in research and development (R&D), the development of sophisticated automated peptide synthesizers with advanced capabilities & functionalities. Furthermore, rising demand & applications of peptides in pharmaceuticals is likely to uplift market growth in coming years.
The prominent players operating in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland).
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific, Inc. (US)
Thermo Fisher Scientific, Inc. is one of the leading player in the peptide synthesis market in 2022. The company’s leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of organic and inorganic growth strategies. The company has adopted different growth strategies, such as deals that include agreements, and acquisitions, to maintain its leading position in the peptide synthesis market. Thermo Fisher Scientific has concentrated its focus on launching new technologies. For example, In 2021, Thermo Fisher Scientific launched novel capillary chromatography columns for proteomics, clinical peptides, and biopharmaceutical research laboratories.
Merck KGaA (Germany)
Merck KGaA is a global science and technology company that operates across the healthcare, life sciences, and performance materials sectors. Within the realm of peptide synthesis, Merck offers a comprehensive portfolio of innovative products, technologies, and services to facilitate protein research and analysis. The company actively engages in research collaborations, partnerships, and investments in state-of-the-art technologies, underscoring its commitment to advancing the field of peptide synthesis. The company primarily focuses on inorganic strategies such as agreements. In 2020, Merck entered into a collaboration agreement with the PolyPeptide Group, a leading contract development and manufacturing organization (CDMO) specialized in peptides. The collaboration aimed to develop and manufacture peptide active pharmaceutical ingredients (APIs) for innovative therapeutic applications.
Kaneka Corporation (Japan)
Kaneka Corporation is a leading global company that has a robust products and services portfolio and geographic presence. In the field of peptides, the company has a strong geographic presence through 102 subsidiaries across North America, Europe, Asia Pacific, Latin America, and Africa. With a reputation for reliability and innovation, the company operates in the peptide synthesis market through its subsidiary AnaSpec which is a significant player in this market.
Related Reports:
Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
